ATE373102T1 - Verbessertes in-vitro-synthesesystem - Google Patents

Verbessertes in-vitro-synthesesystem

Info

Publication number
ATE373102T1
ATE373102T1 AT02715053T AT02715053T ATE373102T1 AT E373102 T1 ATE373102 T1 AT E373102T1 AT 02715053 T AT02715053 T AT 02715053T AT 02715053 T AT02715053 T AT 02715053T AT E373102 T1 ATE373102 T1 AT E373102T1
Authority
AT
Austria
Prior art keywords
hydrolysis
vitro synthesis
improved
synthesis system
bonds
Prior art date
Application number
AT02715053T
Other languages
English (en)
Inventor
Deb Chatterjee
Mary Longo
Original Assignee
Invitrogen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Invitrogen Corp filed Critical Invitrogen Corp
Application granted granted Critical
Publication of ATE373102T1 publication Critical patent/ATE373102T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Feeding, Discharge, Calcimining, Fusing, And Gas-Generation Devices (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Vibration Dampers (AREA)
AT02715053T 2001-03-08 2002-03-07 Verbessertes in-vitro-synthesesystem ATE373102T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27382701P 2001-03-08 2001-03-08

Publications (1)

Publication Number Publication Date
ATE373102T1 true ATE373102T1 (de) 2007-09-15

Family

ID=23045560

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02715053T ATE373102T1 (de) 2001-03-08 2002-03-07 Verbessertes in-vitro-synthesesystem

Country Status (8)

Country Link
US (1) US20020168706A1 (de)
EP (1) EP1373570B1 (de)
JP (1) JP4328530B2 (de)
AT (1) ATE373102T1 (de)
CA (1) CA2440531A1 (de)
DE (1) DE60222390T2 (de)
NZ (1) NZ528342A (de)
WO (1) WO2002072890A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030119091A1 (en) * 2001-12-20 2003-06-26 Toru Ezure Cell-free protein synthesis method and extract solution therefor
US20040235029A1 (en) * 2003-04-28 2004-11-25 Lee Jae Moon In vitro translation system
WO2004111203A1 (ja) * 2003-06-10 2004-12-23 Shimadzu Corporation 哺乳動物培養細胞抽出液およびその調製方法、ならびに該抽出液を用いた無細胞系タンパク質合成方法
WO2005033286A2 (en) 2003-10-01 2005-04-14 Invitrogen Corporation Compositions and methods for synthesizing, purifying and detecting biomolecules
JP4091901B2 (ja) * 2003-11-13 2008-05-28 株式会社島津製作所 無細胞系タンパク質合成におけるミクロソーム膜添加による翻訳後修飾方法
CN101014716B (zh) * 2003-11-20 2015-06-10 小利兰·斯坦福大学托管委员会 体外蛋白质合成的改进方法
US20070117179A1 (en) * 2005-09-27 2007-05-24 Invitrogen Corporation In vitro protein synthesis systems for membrane proteins that include adolipoproteins and phospholipid-adolipoprotein particles
WO2008106660A2 (en) * 2007-03-01 2008-09-04 Invitrogen Corporation Isolated phospholipid-protein particles
EP2989202B1 (de) * 2013-04-25 2019-04-10 Sutro Biopharma, Inc. Die verwendung des lambda-gam proteins in der ribosomen-display-technologie
EP4010481A4 (de) 2019-08-09 2023-09-20 Nutcracker Therapeutics, Inc. Mikrofluidische vorrichtungen und verfahren zur verwendung davon
MX2023009947A (es) 2021-02-25 2023-11-17 Ardent Mills Llc Sistemas y metodos para extraer y aislar productos de embrion de trigo purificados.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0566714B1 (de) * 1991-10-11 1997-01-02 Promega Corporation Gekoppelte transkription und translation in zellfreien eukaryoten-extrakten
US5665563A (en) * 1991-10-11 1997-09-09 Promega Corporation Coupled transcription and translation in eukaryotic cell-free extract
JP3434319B2 (ja) * 1993-06-15 2003-08-04 日本製粉株式会社 無細胞タンパク合成系によるタンパクの製造方法
US6168931B1 (en) * 1999-03-17 2001-01-02 The Board Of Trustees Of The Leland Stanford Junior University Enhanced in vitro synthesis of biological macromolecules using a novel ATP regeneration system
WO2000055353A1 (en) * 1999-03-17 2000-09-21 The Board Of Trustees Of The Leland Stanford Junior University In vitro macromolecule biosynthesis methods using exogenous amino acids and a novel atp regeneration system
WO2001021830A1 (en) * 1999-09-24 2001-03-29 Ambion, Inc. Nuclease inhibitor cocktail

Also Published As

Publication number Publication date
JP4328530B2 (ja) 2009-09-09
EP1373570A4 (de) 2005-04-27
NZ528342A (en) 2005-10-28
EP1373570A1 (de) 2004-01-02
WO2002072890A1 (en) 2002-09-19
JP2004524847A (ja) 2004-08-19
DE60222390D1 (de) 2007-10-25
CA2440531A1 (en) 2002-09-19
US20020168706A1 (en) 2002-11-14
WO2002072890A8 (en) 2003-03-13
EP1373570B1 (de) 2007-09-12
DE60222390T2 (de) 2008-06-19

Similar Documents

Publication Publication Date Title
BR0010220A (pt) Compostos de pirimidinona
DK1117771T3 (da) Tørstofformige phytasesammensætninger
ATE431416T1 (de) Enzymatische synthese von deoxyribonucleotiden
HN1999000083A (es) Compuestos de pirrolo(2,3-d) pirimidina
DE60222390D1 (de) Verbessertes in-vitro-synthesesystem
MY135732A (en) 5,6-trimethylenepyrimidin - 4 - one compounds
AU2002359522A1 (en) Compositions and methods of selective nucleic acid isolation
HUP9901640A2 (hu) Foszfolipáz aktivítású fehérje
SG129236A1 (en) Somatic pluripotent cells
PT1165558E (pt) Derivados de pirimido¬6,1-a|isoquinolina-4-ona
TR200003513T2 (tr) Pirolo[2,3d]Pirimidin kompozisyonları ve kullanımları
DE50008164D1 (de) Galactomannan-oligosaccharide und verfahren zu deren herstellung sowie deren verwendung
EE9900105A (et) Bensonaftüridiinid bronhiaalravimitena
AU5630999A (en) Endofucanases and method using same for preparing fuco-oligosaccharides from fucanes, bacterium producing endofucanases and uses of fuco-oligosaccharides for plant protection
WO2003009104A3 (en) Business valuation system and method
MX9300777A (es) Derivados aminoacetilmercapto novedosos utiles como inhibidores de la encefalinasa y la eca
ATE275956T1 (de) Veränderung der dns methyltransferase durch kombinationstherapie
AU3928999A (en) Novel n-oxides
ATE226588T1 (de) Phosphinsäure-derivate
PT1080104E (pt) Certos tiois heteroarilo substituidos inibidores da enzima conversora da endotelina
BG105003A (en) Combinations of protein farnesyltransfer and hmg coa reductase inhibitors and their use to treat cancer
BG100248A (bg) Инхибитори на скваленсинтетаза
DE50110723D1 (de) Isolierte luziferasen sowie deren verwendung
WO2003087054A3 (en) Methods for identifying compounds that modulate enzymatic activity
BR0114884A (pt) Compostos calcilìticos

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties